04.04.2011
German forklift truck maker Kion is set to make its debut on financial markets with its first ever corporate bond, helping to pave the way for a stock exchange listing in the medium term.
In a statement on Friday, the industry No. 2 behind Toyota Industries said the offering would start next week with net proceeds going to refinance its syndicated debt.
more13.01.2011
Thermo Fisher Scientific, a maker of scientific instruments, is pursuing a sale of two lab-testing divisions that may fetch up to $1 billion, Bloomberg said, citing three people familiar with the matter.
Thermo Fisher has hired Goldman Sachs to handle the sale of Athena Diagnostics, which may be sold for $600-$700 million, and Barclays Capital to help it sell Lancaster Labs, which may fetch $200-$300 million, Bloomberg said.
more23.12.2010
Airgas has rejected yet another takeover offer from rival industrial gas producer Air Products, saying a sweetened $5.9 billion bid is just not enough.
Air Products stood firm, though, reiterating on Wednesday that its $70-per-share cash offer is "best and final."
The news sent Airgas shares down 2.8 percent to $61.44, and analysts said arbitrage investors were selling their positions in the belief that a deal was unlikely in the short term.
more14.09.2010
U.S. biotech firm Genzyme said it agreed to sell its genetic-testing business to Labcorp of America Holdings for $925 million in cash.
Genzyme, which recently rejected a takeover bid from French drugmaker Sanofi-Aventis, said its plan to divest two other units - diagnostic products and pharmaceutical intermediates - stays on track and proceeds from the deals may be used to fund the second half its $2 billion stock buyback.
more14.09.2010
Amgen on Monday launched $1.5 billion of debt in a two-part sale. The offering includes $900 million of 10-year notes expected to yield 77 basis points over comparable U.S. treasuries and $600 million of 31-year bonds expected to yield 117 basis points more than U.S. treasuries.
The joint book managers on the sale are Citigroup, Goldman Sachs and Morgan Stanley.
more08.09.2010
Glaxosmithkline said on Wednesday it had hired Goldman Sachs investment banker Simon Dingemans to succeed Chief Financial Officer Julian Heslop, 59, who will retire next March.
Dingemans has more than 25 years experience in investment banking and most recently led Goldman Sachs' european M&A business, Britain's largest drugmaker said.
more03.08.2010
Bankrupt U.S. chemicals company Chemtura Corp has asked a judge to approve $1.025 billion in bankruptcy exit financing to help the company fund operations after it emerges from Chapter 11 protection, according to court documents.
The specialty chemicals maker is urging speed, saying it wants to lock in the agreements now to take advantage of favorable high-yield debt markets and move ahead of the September Labor Day holiday, when financial markets are closed.
more